Composition and methods of use for therapeutic antibodies specific for the IL-12 receptore betal subunit

Details for Australian Patent Application No. 2010230311 (hide)

Owner Novartis AG

Inventors Bardroff, Michael; Carballido Herrera, Jose M.; Della Ducata, Daniela; Heusser, Christoph; Jaeger, Ute; Schwaerzler, Christoph

Agent Davies Collison Cave

Pub. Number AU-B-2010230311

PCT Pub. Number WO2010/112458

Priority 61/165,177 27.04.09 US

Filing date 29 March 2010

Wipo publication date 7 October 2010

Acceptance publication date 16 August 2012

International Classifications

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

13 October 2011 PCT application entered the National Phase

  PCT publication WO2010/112458 Priority application(s): WO2010/112458

16 August 2012 Application Accepted

  Published as AU-B-2010230311

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010230314-Oxadiazole derivatives

2010230294-Radiation curing of coatings